Broadest portfolio gives access to advanced care
"The Lumax 740 series is a broad portfolio of ICDs, CRT-D devices and leads which enables physicians to choose the best device and lead combination for each patient, along with giving those patients the opportunity for potentially lifesaving MRI procedures," explains Professor Antonio Curnis, MD, Director Cardiac Pacing and Electrophysiology Lab, University of Brescia, Brescia City Hospital, Italy.
"Because continuous, reliable monitoring is vitally important - especially for those who suffer from heart failure," continued Professor Curnis, "the Lumax 740 system also integrates a sophisticated remote patient management system. BIOTRONIK Home Monitoring® and the Heart Failure Monitor enhance a patient's quality of life, and patients know that with these features their physicians can track their conditions remotely. It brings them great peace of mind to know they are being monitored and that any adjustments to their therapies can be made earlier."
BIOTRONIK Home Monitoring® is the first and only remote patient management system with FDA and CE approvals for safe reduction of in-office follow-ups and for early detection of clinically relevant events. Studies have demonstrated that BIOTRONIK Home Monitoring® enables an early detection of atrial fibrillation and a significant reduction of hospitalizations (COMPAS(4)) and that it also reduces unnecessary and inappropriate shocks (ECOST(5)).
The new Lumax 740 series is part of BIOTRONIK's technologically advanced tachycardia product portfolio with ProMRI®, which includes 3 ICDs, 1 CRT-D device and 16 leads. The Linoxsmart ICD leads, which have been proven over time to be of the highest quality and reliability, are now approved for MR scanning. In addition to featuring ProMRI® technology, the devices also stand out in the industry because they provide longevities of up to 11 years. Together with its MRI-approved Evia and Estella pacemaker series, BIOTRONIK offers patients the industry's broadest portfolio of implantable cardiac devices approved for MR scanning.
About BIOTRONIK Home Monitoring®
BIOTRONIK has pioneered advances in its BIOTRONIK Home Monitoring® remote patient management system since its first clinical application in the year 2000. The system is unique because it allows continuous, automatic wireless remote monitoring of patient status and device status with daily updates -- all independent of any patient interaction. The technology leads to earlier intervention, as proven by the results of the TRUST(6,7) landmark trial. Today, BIOTRONIK Home Monitoring® is used extensively in more than 5,300 clinics and 56 countries worldwide.
ProMRI® allows patients with a pacemaker, ICD or CRT-D to undergo an MR scan. The BIOTRONIK ProMRI® tachycardia series marks the first time an ICD-/CRT-D portfolio has been designed, tested and approved to make MR scans possible. As a result, physicians have the unique opportunity to select the optimal device from the Lumax 740 series -- offering their patients the most advanced therapy available along with access to MR scans.
About BIOTRONIK SE & Co. KG
As one of the world's leading cardiovascular medical device companies, with several million implanted devices, BIOTRONIK is represented in over 100 countries with its global workforce of more than 5,600 employees. Known for having its fingers on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face and provides the best solutions for all phases of patient care, ranging from diagnosis and treatment to patient management. Quality, innovation and clinical excellence define BIOTRONIK and its growing success -- and deliver confidence and peace of mind to physicians and their patients worldwide.
For more information: www.biotronik.com
(1) For detailed information about ProMRI® including the complete set of conditions and prerequisites please visit www.biotronik.com/promri
(2) Roguin et al., Europace 2008, 10, 336-346.
(3) Morgan Stanley, ICD market, 1996-2009.
(4) Mabo et al., European Heart Journal 2011; doi: 10.1093/eurheartj/ehr419.
(5) Kacet S., presentation at ESC Congress 2011 in Paris, France;
(6) Varma et al., Circulation 2010, 122, 325-332.
(7) Varma et al., Circ Arrhythm Electrophysiol 2010, 3:428-436.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1946332
Senior Director, Global Communications
BIOTRONIK SE & Co. KG
Tel. +49 (0) 30 68905 1602
Email: Email Contact
BIOTRONIK SE & Co. KG
Tel +49 (0) 30 68905-1602
Fax +49 (0) 30 68905-1969
Most Popular Stories
- 15 Myths That Could Ruin Your Hispanic Ad Campaign
- General Motors Names Mary Barra as First Female CEO
- Cold Dis-comfort: Antarctica Set Record of -135.8
- Slow Week Ahead of December FOMC Meeting
- Uruguay Gets Ready for Legal Marijuana
- Oldaker Takes Center Stage at Entrepreneur Awards
- Obama Delivers Speech at Mandela Memorial: Transcript
- Hispanics Seek to Grow School Board Members
- 'Knockout Game': Myth or Menace?
- Russia Says Nyet to Canada North Pole Claim